AR087488A1 - USE OF COMPOSITIONS TO DELAY THE START OF THE CATAGENA HAIR PHASE - Google Patents
USE OF COMPOSITIONS TO DELAY THE START OF THE CATAGENA HAIR PHASEInfo
- Publication number
- AR087488A1 AR087488A1 ARP120102898A ARP120102898A AR087488A1 AR 087488 A1 AR087488 A1 AR 087488A1 AR P120102898 A ARP120102898 A AR P120102898A AR P120102898 A ARP120102898 A AR P120102898A AR 087488 A1 AR087488 A1 AR 087488A1
- Authority
- AR
- Argentina
- Prior art keywords
- extract
- species
- delay
- compositions
- theobroma
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 241000894007 species Species 0.000 abstract 4
- 241000207199 Citrus Species 0.000 abstract 3
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 abstract 3
- 241000219161 Theobroma Species 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 3
- 230000003778 catagen phase Effects 0.000 abstract 3
- 230000031774 hair cycle Effects 0.000 abstract 3
- 230000003834 intracellular effect Effects 0.000 abstract 3
- 241001119526 Paullinia Species 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000011200 topical administration Methods 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Composiciones administradas por vía tópica que contienen como ingrediente activo un extracto de AIlium species, un extracto de Citrus species, un extracto de Paullinia species y un extracto de Theobroma para aumentar a su nivel normal la proteína antiapoptótica Bcl-2 intracelular y así retrasar el inicio de la fase catágena del ciclo del cabello. Un método de intervención para aumentar a su nivel normal la proteína antiapoptótica Bcl-2 intracelular y así retrasar el inicio de la fase catágena del ciclo del cabello que comprende la administración por vía tópica de composiciones que contienen como ingrediente activo un extracto de AIIium species, un extracto de Citrus species, un extracto de Paullinia species y un extracto de Theobroma.Reivindicación 8: Un método de intervención para aumentar a su nivel normal la proteína antiapoptótica Bcl-2 intracelular y así retrasar el inicio de la fase catágena del ciclo del cabello que comprende la administración por vía tópica de una composición que contiene como ingrediente activo un extracto de AIIium species, un extracto de Citrus species, un extracto de PauIlinia species y un extracto de Theobroma.Topically administered compositions that contain as an active ingredient an extract of AIlium species, an extract of Citrus species, an extract of Paullinia species and an extract of Theobroma to increase intracellular Bcl-2 antiapoptotic protein to its normal level and thus delay the onset of the catagen phase of the hair cycle. An intervention method to increase the intracellular Bcl-2 antiapoptotic protein to its normal level and thus delay the onset of the catagen phase of the hair cycle comprising the topical administration of compositions containing as an active ingredient an extract of AIIium species, an extract of Citrus species, an extract of Paullinia species and an extract of Theobroma. Claim 8: An intervention method to increase to the normal level the intracellular Bcl-2 antiapoptotic protein and thus delay the onset of the catagen phase of the hair cycle comprising topical administration of a composition containing as an active ingredient an extract of AIIium species, an extract of Citrus species, an extract of PauIlinia species and an extract of Theobroma.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161521413P | 2011-08-09 | 2011-08-09 | |
| PCT/EP2012/053929 WO2013020719A2 (en) | 2011-08-09 | 2012-03-07 | New use of compositions to delay the onset of the catagen phase of the hair |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR087488A1 true AR087488A1 (en) | 2014-03-26 |
Family
ID=45876715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120102898A AR087488A1 (en) | 2011-08-09 | 2012-08-08 | USE OF COMPOSITIONS TO DELAY THE START OF THE CATAGENA HAIR PHASE |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR087488A1 (en) |
| WO (1) | WO2013020719A2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2862598A1 (en) | 2013-10-16 | 2015-04-22 | Legacy Healthcare Holding Ltd. | Use of a composition for the pigmentation of hair and hairs |
| ES2777250T3 (en) * | 2013-11-08 | 2020-08-04 | Legacy Healthcare Ltd | Method for the treatment of cancer and cancer concomitant diseases |
| FR3109881B1 (en) * | 2020-05-07 | 2022-10-21 | Legacy Healthcare Switzerland Sa | PROCESS FOR IMPROVING THE IMMUN SYSTEM TO ACQUIRE PAN-IMMUNITY |
| JP7796711B2 (en) * | 2023-05-17 | 2026-01-09 | レガシー ヘルスケア（スウィツァランド）ソシエテ アノニム | Long-term treatment of alopecia |
| US11819530B1 (en) * | 2023-05-17 | 2023-11-21 | Legacy Healthcare (Switzerland) Sa | Long term treatment of hair loss |
| WO2024236153A1 (en) * | 2023-05-17 | 2024-11-21 | Legacy Healthcare (Switzerland) Sa | Composition combination for use in the treatment and/or prevention of hair loss |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04342517A (en) * | 1990-07-20 | 1992-11-30 | Yutaka Miyauchi | 5alpha-reductase inhibitor and hair tonic containing the sane inhibitor |
| DE102005010142A1 (en) * | 2005-03-02 | 2005-11-03 | Dr. Kurt Wolff Gmbh & Co. Kg | Composition for activating hair roots, especially to combat androgenetic alopecia, containing synergistic combination of caffeine and plant extract with phyto-estrogenic action |
| FR2912310B1 (en) * | 2007-02-13 | 2009-08-07 | Kasan Sarl | NOVEL COSMETIC AND / OR PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATIONS. |
-
2012
- 2012-03-07 WO PCT/EP2012/053929 patent/WO2013020719A2/en not_active Ceased
- 2012-08-08 AR ARP120102898A patent/AR087488A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013020719A2 (en) | 2013-02-14 |
| WO2013020719A3 (en) | 2013-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016007067A (en) | Lipid microcapsules preferably comprising a retinoid, and composition containing same, method for the production thereof, and use thereof in dermatology. | |
| AR087488A1 (en) | USE OF COMPOSITIONS TO DELAY THE START OF THE CATAGENA HAIR PHASE | |
| WO2012143576A3 (en) | Compounds for preventing, reducing and/or alleviating itchy skin condition(s) | |
| AR084932A1 (en) | OPHTHALMIC COMPOSITION INCLUDING AN ANDROGEN AND ITS USE FOR THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF AN EYE DISEASE RESULTING FROM AN ANDROGENIC DEFICIENCY | |
| CL2014001158A1 (en) | Alkylated piperazine derivative compounds; pharmaceutical composition that includes them; process to prepare the pharmaceutical composition; kit and use in the treatment of immune disorders, cancer, cardiovascular diseases, inflammation, among others. | |
| CO6710926A2 (en) | N-heteroaryl compounds | |
| MX393613B (en) | GEL COMPOSITIONS FOR TRANSDERMAL DELIVERY TO MAXIMIZE DRUG CONCENTRATIONS IN THE STRATUM CORNEUM AND SERUM, AND METHODS OF USING SAME. | |
| MX2014008284A (en) | FORMULATION OF DELAYED RELEASE TO REDUCE THE FREQUENCY OF URINATING AND METHODS OF USE OF THIS. | |
| MX2014008283A (en) | FORMULATION OF PROLONGED RELEASE TO REDUCE THE FREQUENCY OF URINATING AND METHODS OF USE OF THIS. | |
| NZ702472A (en) | Oil/water-emulsion-type topical compositions containing a retinoid | |
| BR112016006171A2 (en) | Foam formulations and device for your delivery | |
| MX2014012742A (en) | COMPOSITION FOR THE TREATMENT OF METABOLIC DISORDERS. | |
| DOP2016000007A (en) | SUBSTITUTED PIRAZOLPIRIDINS | |
| CY1118461T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING AROMATOLOGY INGREDIENTS | |
| CO6660486A2 (en) | Topical pharmaceutical or cosmetic composition useful for the treatment of diseases or conditions that present with a deficit of the maturation of the cornea envelope | |
| HK1222337A1 (en) | Topical composition and carrier for administration of pharmaceutical or cosmetic active ingredients | |
| MX2014014517A (en) | Topical compositions in the form of a gel containing a particular solubilised retinoid. | |
| MX2014014579A (en) | O/w-emulsion-type topical pharmaceutical compositions containing a retinoid. | |
| CL2012002893A1 (en) | Composition of at least one active ingredient of vegetable or synthetic origin thereof, or extract of plant origin containing it, in an aqueous solution, which also comprises lecithin as an encapsulating agent; medicine that understands it; method for its preparation; and its use to treat intestinal parasitosis. | |
| AR084197A1 (en) | COMPOSITION FOR TOPICAL USE FOR THE TREATMENT OF SKIN DISORDERS | |
| MX2016004021A (en) | Medical composition containing a cholesterol absorption inhibitor and cholesterol biosynthesis inhibitor. | |
| BR112013021497A2 (en) | new use of compositions to prevent chemotherapy and radiotherapy-induced alopecia, reduce the impact of the offspring and improve the appearance of regrowth hair | |
| MX373305B (en) | METHOD FOR STABILIZING A COMPOSITION CONTAINING AT LEAST ONE INTERNAL DEHYDRATION PRODUCT OF A HYDROGENATED SUGAR, RESULTING COMPOSITION AND USES THEREOF. | |
| CL2013003588A1 (en) | Pharmaceutical composition in the form of an oral suspension comprising as active ingredient a fraction of flavonoid and as an excipient xanthan gum in the amount of 0.30% w / w to 0.60% w / w; use for the treatment of venous insufficiency. | |
| BR112014018426A8 (en) | COMPOSITION AND DEVICE FOR TRANSDERMAL ADMINISTRATION, AND METHOD FOR ADMINISTERING A PROGESTIN |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |